From October 1, 2021 to December 31, 2021, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 4,139,200 shares, representing 0.67% for CNY 50.95 million under the buyback announced on March 15, 2021.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
4.33 CNY | -0.46% | -0.23% | -32.34% |
06-24 | Wanbangde Pharmaceutical Holding Group Co., Ltd.(XSEC:002082) dropped from S&P Global BMI Index | CI |
05-20 | Wanbangde Pharmaceutical Holding Group Co., Ltd. Approves Dividend for the Year 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-32.34% | 366M | |
+21.80% | 43.81B | |
+30.12% | 23.03B | |
+21.32% | 15.45B | |
+19.05% | 14.4B | |
+58.92% | 12.95B | |
-0.05% | 6.79B | |
-11.45% | 6.49B | |
-8.87% | 5.73B | |
+14.11% | 5.49B |
- Stock Market
- Equities
- 002082 Stock
- News Wanbangde Pharmaceutical Holding Group Co., Ltd.
- Tranche Update on Wanbangde Pharmaceutical Holding Group Co., Ltd.'s Equity Buyback Plan announced on March 15, 2021.